Gujarat Corona Remedies FY26 Results: Strong Revenue and Profit Growth Impress Investors
The pharmaceutical landscape of Western India is witnessing a paradigm shift with the “Burst Performance” of local players consolidating their global footprint. Gujarat Corona Remedies sees 17% revenue growth, PAT up 33% in FY26 In a major announcement that has caught the attention of market analysts and healthcare investors. These solid numbers demonstrate the company’s…